International Clinical Trial: Efficacy and Safety of Anlotinib and Finotonlimab Combined with Induction Chemotherapy in Patients with Locally Advanced Hypopharyngeal Cancer: A Single-Center, Single-Arm, Exploratory Phase II Clinical Study

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132900) titled 'Efficacy and Safety of Anlotinib and Finotonlimab Combined with Induction Chemotherapy in Patients with Locally Advanced Hypopharyngeal Cancer: A Single-Center, Single-Arm, Exploratory Phase II Clinical Study' on Sept. 20.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Fujian Medical University Union Hospital

Condition: Persistent severe pharyngalgia, ipsilateral radiating otalgia and intractable pharyngeal foreign body sensation in patients with locally advanced hypopharyngeal carcinoma.

Intervention: Trial group:Received 3 cycles of docetaxel (75mg/m^2, D1) + carboplatin (AUC...